Pharmaceutical

Filter

Current filters:

None

Popular Filters

6576 to 6600 of 6944 results

US investment in health research remains stagnant, new research shows

11-09-2011

In 2010, the US public and private sectors invested $140.5 billion in 2010 on research to find new ways…

FinancialNorth AmericaPharmaceuticalResearch

USA’s Affordable Care Act delivers lower costs to more seniors with Medicare, new data shows

11-09-2011

Quoting new data, the US Centers for Medicare & Medicaid Services (CMS) says that more seniors and people…

FinancialHealthcareNorth AmericaPharmaceutical

Vast majority of surveyed European physicians see need for ultra-fast insulins

11-09-2011

The vast majority of surveyed physicians in the EU5 countries (France, Germany, Italy, Spain and the…

DiabetesEuropeMarkets & MarketingPharmaceutical

F-Star and Merck Serono in up to 492 million-euro collaboration on novel targeted biologics

09-09-2011

Austrian biotech firm F-Star GmbH has entered into a research, license and commercialization agreement…

BiotechnologyF-StarLicensingMerck KGaAMerck SeronoPharmaceuticalResearch

Draft guidance from UK's NICE recommends clinical trial for COPD drug Daxas

09-09-2011

New draft guidance from the UK's drug watchdog the National Institute for Health and Clinical Excellence…

DaxasEuropeMerck & CoNycomedPharmaceuticalPricingRegulationRespiratory and Pulmonary

Teva and Alcobra ADHD candidate meets primary endpoint in Ph II

09-09-2011

Israeli generics drug giant Teva Pharmaceutical Industries (Nasdaq: TEVA) and start-up drug developer…

AlcobraMetadoxineNeurologicalPharmaceuticalResearchTeva Pharmaceutical Industries

Alkermes shareholders vote in favor of merger with Elan Drug Technology

09-09-2011

Shareholders of USA-based Alkermes (Nasdaq; ALKS) have voted to approve the previously-announced $960…

AlkermesElanElan Drug TechnologiesMergers & AcquisitionsPharmaceutical

Senior appointments at Novo Nordisk and Sucampo

08-09-2011

The US unit of Danish insulin giant Novo Nordisk (NVO: N) has appointed Eddie Li, as vice president,…

ManagementNovo NordiskPharmaceuticalSucampo

TNF inhibitors used for rheumatoid arthritis associated with increased skin cancer risk

08-09-2011

Biological agents used to treat rheumatoid arthritis seem to be associated with an increased risk of…

Anti-Arthritics/RheumaticsBiotechnologyPharmaceuticalResearch

Global pharmacovigilance spending forecast to reach $15.46 billion by 2015

08-09-2011

Spending on pharmacovigilance will reach a value of $15.46 billion by 2015, compared with just under…

BiotechnologyFinancialGlobalPharmaceuticalRegulation

Major global expansion of Rx-to-OTC switch forecast by 2016

08-09-2011

There is a strong case that selected prescription (Rx) drugs today will gain over-the-counter (OTC) status…

GlobalMarkets & MarketingPharmaceutical

CimaVax-EGF, the first vaccine against lung cancer, debuts in Cuba

08-09-2011

Following regulatory approval earlier this year, Cuban medical authorities have launched the world's…

CimaVax-EGFMarkets & MarketingOncologyPharmaceuticalVaccines

Irritable bowel syndrome drug market set to grow to $1.6 billion by 2018

08-09-2011

The global irritable bowel syndrome (IBS) therapeutics market was valued at $655.8 million in 2010, and…

Gastro-intestinalsMarkets & MarketingPharmaceutical

Exec appointments at SkyePharma, Impax, Ariad and Regeneron

07-09-2011

UK-based drug delivery specialist SkyePharma (LSE: SKP) has appointed Pierre Delavaud as executive vice…

Ariad PharmaceuticalsGenericsImpax LaboratoriesManagementPharmaceuticalRegeneronSkyepharma

Novo Nordisk extends free insulin and diabetes care program to India

07-09-2011

Denmark’s Novo Nordisk (NVO: N), the world’s largest insulin maker, yesterday launched its…

Asia-PacificDiabetesMarkets & MarketingNovo NordiskPharmaceutical

Germany dedicates billions to fund health care research

07-09-2011

Germany has allocated over 5.5 billion euros (nearly $8 billion) in federal grants to support health…

BiotechnologyEuropeFinancialPharmaceuticalResearch

Sanofi sets 5% sales growth goal; views Genzyme synergies, patent losses and R&D

07-09-2011

Christopher Viehbacher, chief executive of French drug major Sanofi (Euronext: SAN), says the company…

FinancialGenzymePharmaceuticalResearchSanofi

Disappointing FDA briefing papers on Bayer/J&J’s Xarelto

07-09-2011

US Food and Drug Administration staffers posted a negative picture for German drug major Bayer (BAY:…

BayerCardio-vascularJohnson & JohnsonNorth AmericaPharmaceuticalRegulationXarelto

Takeda’s Mepact backed by UK’s NICE for osteosarcoma, after previous negative opinion

07-09-2011

In a U-turn by the UK drug watchdog, in its latest appraisal, the National Institute for Health and Clinical…

EuropeMepactOncologyPharmaceuticalPricingRegulationTakeda Pharmaceuticals

ViroPharma's Buccolam gets EU approval for treatment of pediatric acute seizures

07-09-2011

USA-based ViroPharma (Nasdaq: VPHM) said yesterday that the European Commission has granted a Centralized…

BuccolamEuropeNeurologicalPharmaceuticalRegulationViroPharma

Novartis aims to become leading producer of innovative drugs in Russia

06-09-2011

Swiss pharmaceutical major Novartis (NOVN: VX) plans to become a lead partner of the Russian government…

FinancialMarkets & MarketingNovartisPharmaceutical

6576 to 6600 of 6944 results

Back to top